REG - Brand Architekts Grp - Rule 19.6(c) confirmation

Brand ArchitektsAnnouncement

31/05/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230531:nRSe0676Ba&default-theme=true

RNS Number : 0676B  Brand Architekts Group PLC  31 May 2023

THE FOLLOWING ANNOUNCEMENT IS BEING MADE PURSUANT TO THE REQUIREMENTS OF RULE
19.6(C) OF THE CITY CODE ON TAKEOVERS AND MERGERS, WHICH, AMONGST OTHER
THINGS, REQUIRES A PARTY TO AN OFFER TO MAKE AN ANNOUNCEMENT AT THE END OF THE
PERIOD OF 12 MONTHS FROM THE DATE ON WHICH THE OFFER PERIOD ENDED CONFIRMING
WHETHER IT HAS TAKEN, OR NOT TAKEN, THE COURSE OF ACTION SET OUT IN ITS STATED
INTENTIONS

 31 May 2023

Brand Architekts Group PLC

 ("Brand Architekts" or the "Group")

Rule 19.6(c) confirmation with respect to stated post-offer intentions in
regard to InnovaDerma Plc

 

Brand Architekts Group Plc announces that, further to the completion of the
recommended merger with InnovaDerma Plc, which became effective by means of a
Court-sanctioned Scheme of Arrangement on 31 May 2022, it has duly confirmed
in writing to The Panel on Takeovers and Mergers in accordance with the
requirements of Rule 19.6(c) of the City Code on Takeovers and Mergers ("the
Code") that it has complied with the post-offer statements of intent made
pursuant to Rules 2.7(c)(viii) and 24.2 of the Code, as originally detailed in
the announcement of 31 March 2022 and the scheme document published on 25
April 2022.

 

 For further information please contact:

 Brand Architekts Group PLC                                    via Alma

 Quentin Higham / Tom Carter
 Singer Capital Markets        (Nominated adviser and broker)  020 7496 3000

 Shaun Dobson / Jen Boorer
 Alma PR                                                       0203 405 0205

 Josh Royston / Sam Modlin

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  OUPFZGFKKGLGFZM